NCT05802459 Evaluation of the Functional Status of Jejunoplasty and Coloplasty and Its Impact on Quality of Life (CEREC)
| NCT ID | NCT05802459 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hospital Universitari de Bellvitge |
| Condition | Quality of Life |
| Study Type | OBSERVATIONAL |
| Enrollment | 36 participants |
| Start Date | 2022-12-15 |
| Primary Completion | 2025-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 36 participants in total. It began in 2022-12-15 with a primary completion date of 2025-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this prospective population-based cohort study is to assess: * The evolution of the functional status of patients undergoing complex esophageal reconstruction * Its impact on quality of life, depending on the type of conduit performed. Participants * Will be asked to complete different quality of life questionnaires during every follow-up visit * Will undergo additional tests to assess functionality
Eligibility Criteria
Inclusion Criteria: * Adult patients (≥ 18 years of age) and of both gender. * Candidates for complete esophageal reconstruction with cervical anastomosis, regardless of the etiology of the esophagectomy. * Decision to indicate a coloplasty (+/- supercharged) or jejunoplasty (free, pedunculated +/- supercharged) as surgical technique after evaluation by the UREC Committee. * Acceptance to participate in the study and comply with the program of procedures (schedule of visits). * Signing of the informed consent. Exclusion Criteria: * Patients who withdraw their informed consent at any time during the course of the study.
Contact & Investigator
Leandre Farran
STUDY DIRECTOR
Hospital Universitari de Bellvitge
Frequently Asked Questions
Who can join the NCT05802459 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Quality of Life. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05802459 currently recruiting?
Yes, NCT05802459 is actively recruiting participants. Contact the research team at mmiro@bellvitgehospital.cat for enrollment information.
Where is the NCT05802459 trial being conducted?
This trial is being conducted at Barcelona, Spain.
Who is sponsoring the NCT05802459 clinical trial?
NCT05802459 is sponsored by Hospital Universitari de Bellvitge. The principal investigator is Leandre Farran at Hospital Universitari de Bellvitge. The trial plans to enroll 36 participants.